Cancer
Biomarker Analysis Tracks AZD2811 in SCLC Trial
In a compelling leap forward for oncology, recent findings from a Phase I dose-expansion study illuminate the promising utility of...
Leading Cancer Scientist Thales “PapaG” Papagiannakopoulos Joins Salk Institute
The Salk Institute has announced a major addition to its world-leading cancer research faculty with the appointment of Dr. Thales...
Leukemia Research Reactivates Silenced Gene in Mice: A Potential Breakthrough for Human Therapies
In a groundbreaking advancement that could rewrite the therapeutic landscape of acute myeloid leukemia (AML), researchers at The Jackson Laboratory...
Redesigned Endoscope Introduces Innovative Approach for Early Detection of Ovarian Cancer
Ovarian cancer remains one of the deadliest gynecologic malignancies worldwide, primarily due to its stealthy nature and the difficulty in...
Reprogramming Key Immune ‘Gatekeeper’ Cell Could Enhance Cancer Immunotherapy
In a groundbreaking study published in the renowned journal Science, researchers at St. Jude Children’s Research Hospital have unveiled a...
University of Colorado Anschutz Gates Institute Secures First-Ever U.S. FDA Approval for Campus-Developed CAR T-Cell Therapy
In a groundbreaking development poised to redefine the landscape of blood cancer treatment, the University of Colorado Anschutz Gates Institute...
Prize-Winning Research Reprograms Tumor Cells to Activate Antitumor Immunity
In a remarkable stride towards redefining cancer treatment paradigms, Dr. Fábio Rosa has emerged as a transformative figure in the...
Lentinus edodes-Derived β-Glucan Suppresses Human Cervical Cancer Progression via DMBT1 Pathway
In the relentless quest for innovative cancer therapies, natural compounds have continuously emerged as a promising frontier. Over the past...
Stard7: An Emerging but Mysterious Factor in Colorectal Cancer
A groundbreaking study spearheaded by researchers at the University of Liège reveals a complex and somewhat paradoxical role for the...
Mount Sinai Pioneers World’s First Liver Cancer Treatment Using Innovative Flexible Scheduling Approach
Mount Sinai Health System has marked a groundbreaking advancement in the treatment of liver cancer by becoming the first healthcare...
Mount Sinai Study Reveals Lung Cancer Surgery is Safe for Numerous Patients Aged Over 80
In a groundbreaking study that challenges common perceptions about age and cancer treatment, researchers at the Icahn School of Medicine...
New Study Suggests Biomarker Test Could Enhance Risk Assessment for HPV-Linked Throat Cancer
A groundbreaking study published in JAMA Otolaryngology – Head and Neck Surgery reveals transformative insights into the application of a...
Hidden Danger After Remission: Therapy-Related Myeloid Neoplasms in Female Cancer Survivors
Advancements in the diagnosis and treatment of female-specific cancers such as breast and ovarian cancer have significantly improved patient survival...
Radiation Therapy Enhances Treatment Outcomes for ‘Supermassive’ Bile Duct Tumors
In a groundbreaking development in the treatment of intrahepatic cholangiocarcinoma, a rare and aggressive form of bile duct cancer originating...
Faecal Hemoglobin Improves Colorectal Cancer Survival
A groundbreaking study published in the British Journal of Cancer on April 2, 2026, has unveiled significant advancements in the...
NCCN Foundation Unveils Annual Awards to Empower Next-Generation Leaders in Cancer Innovation
The National Comprehensive Cancer Network® (NCCN®) has proudly announced the recipients of the 2026 NCCN Foundation® Young Investigator Awards, a...
Exploring Tumor Microbiota: Unlocking New Horizons in Cancer Biology
The tumor microbiota, an intricate assemblage of bacteria, fungi, viruses, and various microorganisms embedded within tumor tissues, has surged into...
Robotic Bronchoscopy: A Safer, Faster Breakthrough in Lung Cancer Diagnosis
In recent years, lung cancer screening programs across the United States have brought to light approximately 1.6 million suspicious lung...
Massey Pioneers New Therapeutic Standard for Stage III Colon Cancer Patients
In a landmark advancement for the treatment of stage III colon cancer characterized by deficient DNA mismatch repair (dMMR), researchers...
First-in-Class Radio-Theranostic Developed Using Novel Antibody from UT MD Anderson
Researchers at The University of Texas MD Anderson Cancer Center have announced a transformative breakthrough in cancer therapy with the...
